NCT02433236View on ClinicalTrials.gov

Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2015

Conditions
IGA Nephropathy
Interventions
DRUG

Fostamatinib Disodium tablet 100 mg

DRUG

Fostamatinib Disodium tablet 150 mg

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY